Study of Prevalence of Eating Disorder in Liver Transplant Patients
NCT ID: NCT06093919
Last Updated: 2024-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
118 participants
OBSERVATIONAL
2024-02-12
2024-08-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondary objectives of the study are to:
* Determine the prevalence of binge eating disorders in liver transplant patients following alcoholic cirrhosis, evaluated by the Bulimia Test;
* Study the association between the presence of eating disorder behaviours and liver damage : hepatic steatosis and fibrosis determined by Fibroscan (Transient elastography and controlled attenuation parameter)
* Study the association between presence of eating disorder behaviours and alcohol use disorder, measured by Alcohol Use Disorders Identification Test-Consumption
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Description and Evaluation of Eating Disorders in Elite Athletes (TCA SHN)
NCT01544400
Effects of Fecal Microbiota Transplantation
NCT07196189
Evaluation of Hospitalization for Anorexia Nervosa (EVALuation de l'Apport de l'HOSPITalisation Pour Anorexie Mentale : EVALHOSPITAM)
NCT00910169
Adult Eating Disorder Assessment Study
NCT06103929
Evaluation of the Clinical, Neuropsychological and Psychosocial Situation of Patient With Eating Disorders.
NCT02829645
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Liver transplant patients
This cohort will consist of all liver transplant patients followed between 01/01/2023 and 06/30/2024
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* had a liver transplant and followed at University Hospital of Poitiers
* responded to the Bulimia Test-Revised and to the Alcohol Use Disorders Identification Test-Consumption
* had a Fibroscan within the year
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Henri Laborit
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Henri Laborit
Poitiers, , France
University Hospital of Poitiers (CHU de Poitiers)
Poitiers, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
F20230719110020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.